The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
The Possibility of Systematic Research Fraud Targeting Under-Studied Human Genes: Causes, Consequences, and Potential Solutions
Open accessAbstract
A major reason for biomarker failure is the selection of candidate biomarkers based on inaccurate or incorrect published results. Incorrect research results leading to the selection of unproductive biomarker candidates are largely considered to stem from unintentional research errors. The additional possibility that biomarker research may be actively misdirected by research fraud has been given comparatively little consideration. This review discusses what we believe to be a new threat to biomarker research, namely, the possible systematic production of fraudulent gene knockdown studies that target under-studied human genes. We describe how fraudulent papers may be produced in series by paper mills using what we have described as a ‘theme and variations’ model, which could also be considered a form of salami slicing. We describe features of these single-gene knockdown publications that may allow them to evade detection by journal editors, peer reviewers, and readers. We then propose a number of approaches to facilitate their detection, including improved awareness of the features of publications constructed in series, broader requirements to post submitted manuscripts to preprint servers, and the use of semi-automated literature screening tools. These approaches may collectively improve the detection of fraudulent studies that might otherwise impede future biomarker research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Experiments that analyse individual genes typically require nucleotide sequence reagents as either targeting and/or control reagents (8, 11).”
From Identification of human gene research articles with wrongly identified nucleotide sequences (2022) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“We have proposed that nucleotide sequences may be particularly prone to error, as they can be affected by different error types that are very challenging to detect by eye (8, 11, 12).”
From Identification of human gene research articles with wrongly identified nucleotide sequences (2022) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As such, wrongly identified sequences are likely to represent unintended hidden errors that persist when sequence identities are not actively checked during manuscript preparation or review (8, 11, 12).”
From Identification of human gene research articles with wrongly identified nucleotide sequences (2022) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Whereas genuine gene research requires time, expertise, and material resources, the mass production of fraudulent gene research articles by paper mills could be quicker and cheaper by orders of magnitude (8).”
From Identification of human gene research articles with wrongly identified nucleotide sequences (2022) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“because genuine pre-clinical gene research requires specialised expertise, time, and material resources (13), the mass production of fraudulent gene research articles could be quicker and cheaper by orders of magnitude (8).”
From Identification of human gene research articles with wrongly identified nucleotide sequences (2022) · cites this paper as [8]
Experimental — accuracy not yet measured
27 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
19 retracted
Retraction note to multiple articles in Tumor Biology
Stigbrand, T. (2017) · Tumor Biology · doi:10.1007/s13277-017-5487-6 · Cited by 57
RetractedWang, L., Zhang, Y., Lv, W., Lu, J., Mu, J., Liu, Y., & Dong, P. (2015) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12573 · Cited by 21
RetractedHuang, W., Chen, D., Li, N., & Wang, L. (2017) · PubMed Central · doi:10.22034/apjcp.2017.18.10.2891 · Cited by 20
RetractedLi, Y.-L., Gao, Y., Xu, Y., Sun, X., Song, X., Ma, H., & Yang, M. (2014) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12428 · Cited by 17
RetractedRetracted: Tumor Protein D52-Like 2 Contributes to Proliferation of Breast Cancer Cells
Yang, M., Wang, X., Jia, J., Gao, H., Chen, P., Sha, X., & Wu, S. (2015) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2014.1723 · Cited by 13
RetractedHe, Y., Chen, F., Cai, Y., & Chen, S. (2016) · Cell Biology International · doi:10.1002/cbin.10593 · Cited by 8
RetractedRetracted: Tumor Protein D52-Like 2 Accelerates Gastric Cancer Cell Proliferation In Vitro
Xu, J., Wang, W., Zhu, Z., Wei, Z., Yang, D., & Cai, Q. (2015) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2014.1766 · Cited by 7
RetractedQi, Y., Hu, T., Li, K., Ye, R., & Ye, Z. (2015) · Journal of Breast Cancer · doi:10.4048/jbc.2015.18.3.218 · Cited by 6
RetractedSUN1 silencing inhibits cell growth through G0/G1 phase arrest in lung adenocarcinoma
Huang, W., Huang, H., Wang, L., Hu, J., & Song, W. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s79727 · Cited by 4
RetractedRetraction – Down-regulation of GPR137 expression inhibits proliferation of colon cancer cells
Zhang, K., Shen, Z., Liang, X., Liu, T., Wang, T., & Jiang, Y. Z. (2018) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmy057 · Cited by 4
RetractedInternational, B. R. (2017) · BioMed Research International · doi:10.1155/2017/7640820 · Cited by 3
RetractedRetracted: Long Noncoding RNA KIAA0125 Potentiates Cell Migration and Invasion in Gallbladder Cancer
International, B. R. (2017) · BioMed Research International · doi:10.1155/2017/3471417 · Cited by 3
RetractedRetraction notice to: Myosin VI contributes to malignant proliferation of human glioma cells
Xu, R., Fang, X.-H., & Zhong, P. (2017) · The Korean Journal of Physiology & Pharmacology · doi:10.4196/kjpp.2017.21.5.565 · Cited by 2
Retracted(2017) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2014.1766.retract · Cited by 2
Retracted(2017) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2014.1723.retract · Cited by 2
RetractedQi, Y., Hu, T., Lin, K., Ye, R., & Ye, Z. (2018) · Journal of Breast Cancer · doi:10.4048/jbc.2018.21.1.102 · Cited by 2
Retracted(2017) · Europe PMC (PubMed Central) · doi:10.22034/apjcp.2017.18.10.2893 · Cited by 2
Retracted(2018) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13339 · Cited by 1
Retracted(2018) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13422 · Cited by 1
RetractedBasic local alignment search tool
Altschul, S. F., Gish, W., Miller, W., Myers, E. W., & Lipman, D. J. (1990) · Journal of Molecular Biology · doi:10.1006/jmbi.1990.9999 · Cited by 98,669
Fanelli, D. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005738 · Cited by 1,911
Phases of Biomarker Development for Early Detection of Cancer
Pepe, M. S., Etzioni, R., Feng, Z., Potter, J. D., Thompson, M. L., Thornquist, M., Winget, M., & Yasui, Y. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.14.1054 · Cited by 1,686
The prevalence of statistical reporting errors in psychology (1985–2013)
Nuijten, M. B., Hartgerink, C. H. J., van Assen, M. A. L. M., Epskamp, S., & Wicherts, J. M. (2016) · Behavior Research Methods · doi:10.3758/s13428-015-0664-2 · Cited by 510
Precision diagnostics: moving towards protein biomarker signatures of clinical utility in cancer
Borrebaeck, C. A. K. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.153 · Cited by 435
Why has the number of scientific retractions increased?
Steen, R. G., Casadevall, A., & Fang, F. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068397 · Cited by 415
Edwards, A. M., Isserlin, R., Bader, G. D., Frye, S. V., Willson, T. M., & Yu, F. H. (2011) · Nature · doi:10.1038/470163a · Cited by 411
Evolution of Translational Omics: Lessons Learned and the Path Forward
Micheel, C., Nass, S. J., & Omenn, G. S. (2013) · Cited by 365
Intended and unintended consequences of a publish‐or‐perish culture: A worldwide survey
van Dalen, H. P., & Henkens, K. (2012) · Journal of the American Society for Information Science and Technology · doi:10.1002/asi.22636 · Cited by 355
Drucker, E., & Krapfenbauer, K. (2013) · EPMA Journal · doi:10.1186/1878-5085-4-7 · Cited by 349 · cited 1×
“human genes, (2) many individual biological or disease systems in which under-studied genes can be examined, (3) growing numbers of specialist journals seeking manuscripts to publish, (4) inadequate peer review standards at some journals, and (5) a lack of content-expert peer reviewers may unwittingly produce a fertil…”
BackgroundPertea, M., Shumate, A., Pertea, G., Varabyou, A., Breitwieser, F. P., Chang, Y.-C., Madugundu, A. K., Pandey, A., & Salzberg, S. L. (2018) · Genome Biology · doi:10.1186/s13059-018-1590-2 · Cited by 335
Scientific Misconduct and the Myth of Self-Correction in Science
Stroebe, W., Postmes, T., & Spears, R. (2012) · Perspectives on Psychological Science · doi:10.1177/1745691612460687 · Cited by 323
Large-scale investigation of the reasons why potentially important genes are ignored
Stoeger, T., Gerlach, M., Morimoto, R. I., & Nunes Amaral, L. A. (2018) · PLOS Biology · doi:10.1371/journal.pbio.2006643 · Cited by 261
Getting pharmaceutical R&D back on target
Bunnage, M. E. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.581 · Cited by 258
Hvistendahl, M. (2013) · Science · doi:10.1126/science.342.6162.1035 · Cited by 256
Reproducibility: A tragedy of errors
Allison, D. B., Brown, A. W., George, B. J., & Kaiser, K. A. (2016) · Nature · doi:10.1038/530027a · Cited by 255
Choosing experiments to accelerate collective discovery
Rzhetsky, A., Foster, J. G., Foster, I. T., & Evans, J. A. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1509757112 · Cited by 249
The human genome and drug discovery after a decade. Roads (still) not taken
Isserlin, R., Bader, G. D., Edwards, A. M., Frye, S. V., Willson, T. M., & Yu, F. H. (2011) · arXiv (Cornell University) · doi:10.48550/arxiv.1102.0448 · Cited by 232
Kern, S. E. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-3232 · Cited by 231 · cited 1×
“human genes, (2) many individual biological or disease systems in which under-studied genes can be examined, (3) growing numbers of specialist journals seeking manuscripts to publish, (4) inadequate peer review standards at some journals, and (5) a lack of content-expert peer reviewers may unwittingly produce a fertil…”
BackgroundPublishing: The peer-review scam
Ferguson, C., Marcus, A., & Oransky, I. (2014) · Nature · doi:10.1038/515480a · Cited by 228
What errors do peer reviewers detect, and does training improve their ability to detect them?
Schroter, S., Black, N., Evans, S., Godlee, F., Osorio, L., & Smith, R. (2008) · Journal of the Royal Society of Medicine · doi:10.1258/jrsm.2008.080062 · Cited by 226
Gene annotation bias impedes biomedical research
Haynes, W. A., Tomczak, A., & Khatri, P. (2018) · Scientific Reports · doi:10.1038/s41598-018-19333-x · Cited by 192
Pragmatic issues in biomarker evaluation for targeted therapies in cancer
de Gramont, A., Watson, S., Ellis, L. M., Rodón, J., Tabernero, J., de Gramont, A., & Hamilton, S. R. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.202 · Cited by 176 · cited 1×
“human genes, (2) many individual biological or disease systems in which under-studied genes can be examined, (3) growing numbers of specialist journals seeking manuscripts to publish, (4) inadequate peer review standards at some journals, and (5) a lack of content-expert peer reviewers may unwittingly produce a fertil…”
BackgroundCommon pitfalls in preclinical cancer target validation
Kaelin, W. G. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.32 · Cited by 175
Waste, Leaks, and Failures in the Biomarker Pipeline
Ioannidis, J. P. A., & Bossuyt, P. M. M. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2016.254649 · Cited by 172
Implementation of proteomic biomarkers: making it work
Mischak, H., Ioannidis, J. P. A., Argiles, A., Attwood, T. K., Bongcam‐Rudloff, E., Broenstrup, M., Charonis, A., Chrousos, G. P., Delles, C., Dominiczak, A., et al. (2012) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2012.02674.x · Cited by 169
Validation of New Cancer Biomarkers: A Position Statement from the European Group on Tumor Markers
Duffy, M. J., Sturgeon, C. M., Sölétormos, G., Barak, V., Molina, R., Hayes, D. F., Diamandis, E. P., & Bossuyt, P. M. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2015.239863 · Cited by 159 · cited 1×
“human genes, (2) many individual biological or disease systems in which under-studied genes can be examined, (3) growing numbers of specialist journals seeking manuscripts to publish, (4) inadequate peer review standards at some journals, and (5) a lack of content-expert peer reviewers may unwittingly produce a fertil…”
BackgroundLinking groupthink to unethical behavior in organizations
Sims, R. R. (1992) · Journal of Business Ethics · doi:10.1007/bf01686345 · Cited by 142
Tijdink, J. K., Bouter, L. M., Veldkamp, C. L. S., van de Ven, P. M., Wicherts, J. M., & Smulders, Y. M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163251 · Cited by 134
Labbé, C., & Labbé, D. (2013) · Scientometrics · doi:10.1007/s11192-012-0781-y · Cited by 132
Self-citationTian, M., Su, Y., & Ru, X. (2016) · Publications · doi:10.3390/publications4020009 · Cited by 129
Research Misconduct: The Poisoning of the Well
Smith, R. W. (2006) · Journal of the Royal Society of Medicine · doi:10.1258/jrsm.99.5.232 · Cited by 128
Glimmers in illuminating the druggable genome
Rodgers, G., Austin, C., Anderson, J., Pawlyk, A., Colvis, C., Margolis, R., & Baker, J. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.252 · Cited by 126
Suspected research fraud: difficulties of getting at the truth
White, C. (2005) · BMJ · doi:10.1136/bmj.331.7511.281 · Cited by 124
Perspective: Research Misconduct
Kornfeld, D. S. (2012) · Academic Medicine · doi:10.1097/acm.0b013e318257ee6a · Cited by 102
The tumor protein D52 family: many pieces, many puzzles
Boutros, R., Fanayan, S., Shehata, M., & Byrne, J. A. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.10.112 · Cited by 95
Self-citationResearch Misconduct: The Poisoning of the Well
Smith, R. W. (2006) · Journal of the Royal Society of Medicine · doi:10.1177/014107680609900514 · Cited by 85
The growth of science and database coverage
Michels, C., & Schmoch, U. (2012) · Scientometrics · doi:10.1007/s11192-012-0732-7 · Cited by 83
Norms, competition and visibility in contemporary science: The legacy of Robert K. Merton
Bucchi, M. (2014) · Journal of Classical Sociology · doi:10.1177/1468795x14558766 · Cited by 82
Life cycles of successful genes
Hoffmann, R., & Valencia, A. (2003) · Trends in Genetics · doi:10.1016/s0168-9525(02)00014-8 · Cited by 69
Penetrating the Omerta of Predatory Publishing: The Romanian Connection
Djurić, D. (2014) · Science and Engineering Ethics · doi:10.1007/s11948-014-9521-4 · Cited by 67
Temporal patterns of genes in scientific publications
Pfeiffer, T., & Hoffmann, R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701315104 · Cited by 64
Jackson, D. W., Walter, G., Daly, J., & Cleary, M. L. (2013) · Journal of Clinical Nursing · doi:10.1111/jocn.12439 · Cited by 58
Nourse, C., Mattéi, M., Gunning, P. W., & Byrne, J. A. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00211-5 · Cited by 52
Self-citationByrne, J. A., & Labbé, C. (2017) · Scientometrics · doi:10.1007/s11192-016-2209-6 · Cited by 50
Self-citationResearch Misconduct—Definitions, Manifestations and Extent
Bornmann, L. (2013) · Publications · doi:10.3390/publications1030087 · Cited by 41
The path to routine use of genomic biomarkers in the cancer clinicPreprint
Boutros, P. C. (2015) · Genome Research · doi:10.1101/gr.191114.115 · Cited by 41 · cited 1×
“In summary, the current landscape that combines (1) many thousands of under-studied Figure 2.”
BackgroundWorld Map of Scientific Misconduct
Ataie‐Ashtiani, B. (2017) · Science and Engineering Ethics · doi:10.1007/s11948-017-9939-6 · Cited by 39
Why serious academic fraud occurs in China
Lin, S. (2012) · Learned Publishing · doi:10.1087/20130105 · Cited by 36
Overflow in science and its implications for trust
Siebert, S., Machesky, L. M., & Insall, R. H. (2015) · eLife · doi:10.7554/elife.10825 · Cited by 34
Downregulation of myosin VI reduced cell growth and increased apoptosis in human colorectal cancer
You, W., Tan, G., Sheng, N., Gong, J., Yan, J., Chen, D., Zhang, H., & Wang, Z. (2016) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmw020 · Cited by 32
Fox, C. W. (2017) · Scientometrics · doi:10.1007/s11192-017-2489-5 · Cited by 32
A quick guide to writing a solid peer review
Nicholas, K. A., & Gordon, W. S. (2011) · Eos · doi:10.1029/2011eo280001 · Cited by 27
Journal Retractions: Some Unique Features of Research Misconduct in China
Liu, X., & Chen, X. (2018) · Journal of Scholarly Publishing · doi:10.3138/jsp.49.3.02 · Cited by 26
Koppers, L., Wormer, H., & Ickstadt, K. (2016) · Science and Engineering Ethics · doi:10.1007/s11948-016-9841-7 · Cited by 25
Georgescu, C., & Wren, J. D. (2018) · Bioinformatics · doi:10.1093/bioinformatics/btx811 · Cited by 20
Yu, H., Zhu, Z., Chang, J., Wang, J., & Shen, X. (2015) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12528 · Cited by 19
Lentivirus-mediated knockdown of tumor protein D52-like 2 inhibits glioma cell proliferation.
Wang, Z., Sun, J., Zhao, Y., Guo, W., Lv, K., & Zhang, Q. (2014) · PubMed · Cited by 17
Knockdown of Myosin VI Inhibits Proliferation of Hepatocellular Carcinoma Cells In Vitro
Ma, X., Yan, J., Chen, W., Du, P., Xie, J., Yu, H.-P., & Wu, H.-R. (2015) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12544 · Cited by 14
Downregulation of TPTE 2P1 Inhibits Migration and Invasion of Gallbladder Cancer Cells
Lv, W., Wang, L., Lu, J., Mu, J., Liu, Y., & Dong, P. (2015) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12533 · Cited by 13
Difficulty in detecting discrepancies in a clinical trial report: 260-reader evaluation
Cole, G. D., Shun-Shin, M. J., Nowbar, A. N., Buell, K. G., Al-Mayahi, F., Zargaran, D., Mahmood, S., Singh, B., Mielewczik, M., & Francis, D. P. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv114 · Cited by 11
Online software spots genetic errors in cancer papers
Phillips, N. (2017) · Nature · doi:10.1038/nature.2017.23003 · Cited by 9
Downregulation of myosin VI reduced cell growth and increased apoptosis in human colorectal cancer
You, W., Tan, G., Sheng, N., Gong, J., Yan, J., Chen, D., Zhang, H., & Wang, Z. (2018) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmy035 · Cited by 6
Liu, X., Min, L., Duan, H., Shi, R., Zhang, W., Hong, S., & Tu, C. (2018) · Medical Oncology · doi:10.1007/s12032-018-1177-5 · Cited by 5
(2016) · PubMed · Cited by 4
Zhao, X., Chen, M., & Tan, J. (2018) · Biological Research · doi:10.1186/s40659-018-0171-x · Cited by 3
Lin, Z., Xiong, L., & Lin, Q. (2018) · Medical Oncology · doi:10.1007/s12032-018-1178-4 · Cited by 3
(2018) · Europe PMC (PubMed Central) · Cited by 3
Pan, Z., Pan, H., Zhang, J., Yang, Y., Liu, H., Yang, Y., Huang, G., Ni, J., Huang, J., & Zhou, W. (2018) · Biological Research · doi:10.1186/s40659-018-0170-y · Cited by 2
Xie, R., Zhang, Y., Shen, C., Cao, X., Gu, S., & Che, X. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s192186 · Cited by 2
(2018) · Europe PMC (PubMed Central) · Cited by 2
(2018) · Europe PMC (PubMed Central) · Cited by 2
Brunette, D. M. (2016) · Endodontic Topics · doi:10.1111/etp.12097 · Cited by 1
(2018) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13382 · Cited by 1
(2018) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13401 · Cited by 1
(2018) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13402 · Cited by 1
Research works printed but not linked: 12
- Retraction, 2016, Int J Clin Exp Med, 9, 12416
- Wang Z, 2014, Cell Mol Biol (Noisy-le-grand), 60, 39
- 10.1016/S0022-2836(05)80360-2 · doi:10.1016/s0022-2836(05)80360-2 · Paper page
- Huang WY, 2017, Asian Pac J Cancer Prev, 18, 2891
- 2017, Biomed Res Int, 2017, 3471417
- 2018, Int J Clin Exp Med, 11, 2917
- 2018, Int J Clin Exp Pathol, 11, 1838
- 2018, Int J Clin Exp Pathol, 11, 1836
- 2017, Asian Pac J Cancer Prev, 18, 2893
- 2017, Biomed Res Int, 2017, 7640820
- 2018, Int J Clin Exp Med, 11, 413
- Acuna DE, 2018, bioRxiv, 269415
Cited by
AI for life: Trends in artificial intelligence for biotechnology
Holzinger, A., Keiblinger, K., Holub, P., Zatloukal, K., & Müller, H. (2023) · New Biotechnology · doi:10.1016/j.nbt.2023.02.001 · Cited by 438
Byrne, J. A., & Christopher, J. (2020) · FEBS Letters · doi:10.1002/1873-3468.13747 · Cited by 133
Self-citationChina bans cash rewards for publishing papers
Mallapaty, S. (2020) · Nature · doi:10.1038/d41586-020-00574-8 · Cited by 100
The raw truth about paper mills
Christopher, J. (2021) · FEBS Letters · doi:10.1002/1873-3468.14143 · Cited by 99
“1754 FEBS Letters 595 (2021) 1751–1757 a 2021 Federation of European Biochemical Societies The Scientists’ Forum”
BackgroundInfluentialThe landscape of biomedical research
González-Márquez, R., Schmidt, L., Schmidt, B. M., Berens, P., & Kobak, D. (2024) · Patterns · doi:10.1016/j.patter.2024.100968 · Cited by 89
Metadata
- Authors
- Byrne, J. A., Grima, N., Capes-Davis, A., & Labbé, C.
- Affiliations
- The University of Sydney (AU)
- CellBank Australia, Children’s Medical Research Institute and The University of Sydney, Westmead, NSW, Australia
- Institut polytechnique de Grenoble (FR)
- Corresponding author
- Byrne, Jennifer A
- Venue
- Biomarker Insights
- Publisher
- SAGE Publications
- Published
- 2019-01
- Volume
- 14
- Pages
- 1177271919829162-1177271919829162
- ISSN
- 1177-2719 (ISSN-L)
- PMC
- PMC6366001
- OpenAlex
- W2914992144
- Cited by
- 34
- References
- 95
- Citations by year
- 2026: 4 · 2025: 1 · 2024: 8 · 2023: 4 · 2022: 4 · 2021: 6 · 2020: 7
- FWCI
- 1.12
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Biomarker Insights (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Post-Truth Initiative (SREI 2020)
- US Office of Research Integrity Project Grant (ORIIR180038-01-00)
- Topics
- Social Sciences › Education › Academic integrity and plagiarism
- Social Sciences › Library and Information Sciences › Academic Publishing and Open Access
- Physical Sciences › Mathematics › Statistics and Probability › Benford’s Law and Fraud Detection
- Keywords
- scientific fraud, paper mills, salami slicing, fraud detection, preprint servers, peer review
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.